Development of a new diagnostic tool for pancreatic cancer: Simultaneous measurement of antibodies against peptides recognized by cytotoxic T lymphocytes

Kurume Medical Journal

Volumn 53, Issue 3-4, 2006, Pages 63-70

  Tanaka, Masahiro ^a   Komatsu, Nobukazu ^a   Yanagimoto, Yasuaki ^b   Oka, Masao ^c   Shichijo, Shigeki ^a,d   Okuda, Seiya ^a   Itoh, Kyogo ^a,d  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KURUME UNIVERSITY   (Japan)

Author keywords

Anti peptide antibody; Diagnosis; Discriminatory analysis; Pancreatic cancer

Indexed keywords

IMMUNOGLOBULIN G; PEPTIDE ANTIBODY;

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISCRIMINANT ANALYSIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PANCREAS CANCER;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; HUMANS; IMMUNOGLOBULIN G; PANCREATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA-BINDING PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33947356720     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.53.63     Document Type: Article

References (16)

1. Denk H, Tappeiner G, Eckerstorfer R, and Holzner JH. Carcinoembryonic antigen (CEA) in gastrointestinal and extra gastrointestinal tumors and its relationship to tumor-cell differentiation. Int J Cancer 1972; 10:262-272.
2. Safi F, Roscher R, and Beger HG. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma. Bull Cancer 1990; 77:83-91.
3. Metzgar RS, Rodriguez N, Finn OJ, Lan MS, Daasch VN et al. Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci USA 1984; 81:5242-5246.
4. Kawa S, Tokoo M, Oguchi H, Furuta S, Homma T et al. Epitope analysis of SPan-1 and DUPAN-2 using synthesized glycoconjugates sialyllact-N-fucopentaose II and sialyllact-N-tetraose. Pancreas 1994; 9:692-697.
5. Argani P, Iacobuzio-Donahue C, Ryu B, Rosty C, Goggins M et al. Mesothelin is over expressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001; 7:3862-3868.
6. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR et al. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is over expressed in pancreatic adenocarcinoma. Cancer Res 2001; 61:4320-4324.
7. Lucarotti ME, Habib NA, Kelly SB, Rothnie ND, Nelson O et al. Clinical evaluation of combined use of CEA, CA19-9 and CA50 in the serum of patients with pancreatic carcinoma. Eur J Surg Oncol 1991; 17:51-53.
8. Ito M, Shichijo S, Tsuda N, Ochi M, Harashima N et al. Molecular basis of T cell-mediated recognition of pancreatic cancer cells. Cancer Res 2001; 61:2038-2046.
9. Shichijo S, Nakao M, Imai Y, Takasu H, Kawamoto M et al. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J Exp Med 1998; 187:277-288.
10. Yang D, Nakao M, Shichijo S, Sasatomi T, Takasu H et al. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res 1999; 59:4056-4063.
11. Gomi S, Nakao M, Niiya F, Imamura Y, Kawano K et al. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs. J Immunol 1999; 163:4994-5004.
12. Mine T, Sato Y, Noguchi M, Sasatomi T, Gohara R et al. Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses. Clin Cancer Res 2004; 10:929-937.
13. Yamamoto K, Mine T, Katagiri K, Suzuki N, Kawaoka T et al. Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer. Oncol Rep 2005; 13:874-883.
14. Komatsu N, Shichijo S, Nakagawa M, and Itoh K. New multiplexed flow cytometric assay to measure anti-peptide antibody: a novel tool for monitoring immune responses to peptides used for immunization. Scand J Clin Lab Invest 2004; 64:535-545.
15. Zhao XY, Yu SY, Da SP, Bai L, Guo XZ et al. A clinical evaluation of serological diagnosis for pancreatic cancer. World J Gastroenterol 1998; 4:147-149.
16. Wu D, Qian JM, Deng RX, Jiang WJ, Chen YJ et al. Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer. Chin J Dig Dis 2006; 7:117-120.